Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways
出版年份 2012 全文链接
标题
Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways
作者
关键词
-
出版物
Journal of Oncology
Volume 2012, Issue -, Pages 1-23
出版商
Hindawi Limited
发表日期
2012-02-07
DOI
10.1155/2012/737981
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Human kallikrein related peptidases 6 and 13 in combination with CA125 is a more sensitive test for ovarian cancer than CA125 alone
- (2017) Nicole M. A. White et al. Cancer Biomarkers
- The Epidermal Growth Factor Receptor Responsive miR-125a Represses Mesenchymal Morphology in Ovarian Cancer Cells
- (2015) Karen D. Cowden Dahl et al. NEOPLASIA
- Identification of a Preneoplastic Gene Expression Profile in Tubal Epithelium of BRCA1 Mutation Carriers
- (2015) Joshua Z. Press et al. NEOPLASIA
- Analysis of mTOR Inhibition-Involved Pathway in Ovarian Clear Cell Adenocarcinoma
- (2011) Makiko Harasawa et al. ACTA HISTOCHEMICA ET CYTOCHEMICA
- Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study
- (2011) A. T. Toriola et al. ANNALS OF ONCOLOGY
- Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
- (2011) P. M. L. H. Vencken et al. ANNALS OF ONCOLOGY
- Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients’ survival
- (2011) J. Dorn et al. ANNALS OF ONCOLOGY
- 2D-PAGE of ovarian cancer: Analysis of soluble and insoluble fractions using medium-range immobilized pH gradients
- (2011) Ratana Lim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency
- (2011) Xiaoqin Yuan et al. BMC CANCER
- Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients
- (2011) Denis Lane et al. BMC CANCER
- Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia
- (2011) Michal Konecny et al. BREAST CANCER RESEARCH AND TREATMENT
- The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer
- (2011) Q Sheng et al. BRITISH JOURNAL OF CANCER
- HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
- (2011) T Van Gorp et al. BRITISH JOURNAL OF CANCER
- Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
- (2011) Timothy A. Yap et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Recent progress in the diagnosis and treatment of ovarian cancer
- (2011) Danijela Jelovac et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ovarian cancer stem cells and inflammation
- (2011) Gil Mor et al. CANCER BIOLOGY & THERAPY
- Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer
- (2011) Yoshimichi Tanaka et al. CANCER BIOLOGY & THERAPY
- Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer
- (2011) Kristin L. White et al. CANCER CAUSES & CONTROL
- Allelic Imbalance in BRCA1 and BRCA2 Gene Expression and Familial Ovarian Cancer
- (2011) J. Shen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer
- (2011) T. V. Clendenen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The Sine Qua Non of Discovering Novel Biomarkers for Early Detection of Ovarian Cancer: Carefully Selected Preclinical Samples
- (2011) I. Jacobs et al. Cancer Prevention Research
- A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer
- (2011) C. S. Zhu et al. Cancer Prevention Research
- Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
- (2011) D. W. Cramer et al. Cancer Prevention Research
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
- (2011) Ayesha B. Alvero et al. CELL CYCLE
- Immune Response in Ovarian Cancer: How Is the Immune System Involved in Prognosis and Therapy: Potential for Treatment Utilization
- (2011) Nikos G. Gavalas et al. Clinical & Developmental Immunology
- IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
- (2011) M. S. Anglesio et al. CLINICAL CANCER RESEARCH
- Trastuzumab and Pertuzumab Produce Changes in Morphology and Estrogen Receptor Signaling in Ovarian Cancer Xenografts Revealing New Treatment Strategies
- (2011) D. Faratian et al. CLINICAL CANCER RESEARCH
- Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population
- (2011) Yong Man Kim et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
- (2011) Martina Montagnana et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Targeting mTOR Signaling Pathway in Ovarian Cancer
- (2011) S. Mabuchi et al. CURRENT MEDICINAL CHEMISTRY
- Searching for synthetic lethality in cancer
- (2011) Rachel Brough et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling
- (2011) Silvia Zecchini et al. EMBO Molecular Medicine
- Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor,RunX1T1in ovarian cancer
- (2011) Kun-Tu Yeh et al. Epigenetics
- Expression of DNA repair genes in ovarian cancer samples: Biological and clinical considerations
- (2011) M. Ganzinelli et al. EUROPEAN JOURNAL OF CANCER
- Cytokine analysis as a tool to understand tumour–host interaction in ovarian cancer
- (2011) Refika Yigit et al. EUROPEAN JOURNAL OF CANCER
- AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration
- (2011) Kyoungsook Park et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Bevacizumab and its use in epithelial ovarian cancer
- (2011) Ursula A Matulonis Future Oncology
- “For All My Family's Sake, I Should Go and Find Out”: An Australian Report on Genetic Counseling and Testing Uptake in Individuals at High Risk of Breast and/or Ovarian Cancer
- (2011) Claire E. Wakefield et al. Genetic Testing and Molecular Biomarkers
- Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer
- (2011) David M. O'Malley et al. GYNECOLOGIC ONCOLOGY
- Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer
- (2011) Jae Hong No et al. GYNECOLOGIC ONCOLOGY
- A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: A Gynecologic Oncology Group Study
- (2011) Robert S. Mannel et al. GYNECOLOGIC ONCOLOGY
- CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian cancer
- (2011) Nicole D. Fleming et al. GYNECOLOGIC ONCOLOGY
- Sorafenib as a third line therapy in patients with epithelial ovarian cancer or primary peritoneal cancer: A phase II study
- (2011) Lubomir Bodnar et al. GYNECOLOGIC ONCOLOGY
- Overview of anti-angiogenic agents in development for ovarian cancer
- (2011) Robert A. Burger GYNECOLOGIC ONCOLOGY
- MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis
- (2011) Catherine Thériault et al. GYNECOLOGIC ONCOLOGY
- Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells
- (2011) Jing Chen et al. GYNECOLOGIC ONCOLOGY
- Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
- (2011) Michael S. Anglesio et al. GYNECOLOGIC ONCOLOGY
- Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer
- (2011) Shiyu Zhang et al. GYNECOLOGIC ONCOLOGY
- Hepatocyte nuclear factor–1β expression in clear cell adenocarcinomas of the bladder and urethra: diagnostic utility and implications for histogenesis
- (2011) Fadi Brimo et al. HUMAN PATHOLOGY
- The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer
- (2011) Shogo Yamamura et al. INTERNATIONAL JOURNAL OF CANCER
- Silencing of CXCR4 Blocks Progression of Ovarian Cancer and Depresses Canonical Wnt Signaling Pathway
- (2011) Jia Wang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer
- (2011) Jonathan A. Ledermann et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Wnt5a as a Predictor in Poor Clinical Outcome of Patients and a Mediator in Chemoresistance of Ovarian Cancer
- (2011) Chunjie Peng et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer
- (2011) Mi Jeong Kwon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activation of AMP-activated Protein Kinase Is Essential for Lysophosphatidic Acid-induced Cell Migration in Ovarian Cancer Cells
- (2011) Eung-Kyun Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- New players in ovarian cancer
- (2011) Alessandro Bovicelli et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancer
- (2011) Chan H Han et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I
- (2011) Lili Gao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer
- (2011) Tugan Bese et al. Journal of Gynecologic Oncology
- Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
- (2011) Yuan Yuan et al. Journal of Hematology & Oncology
- Randomized Phase III Clinical Trial Evaluating Weekly Cisplatin for Advanced Epithelial Ovarian Cancer
- (2011) R. Fruscio et al. JNCI-Journal of the National Cancer Institute
- Cancer stem cell subsets and their relationships
- (2011) Hai-Guang Liu et al. Journal of Translational Medicine
- Polyclonal antitumor immunoglobulin may play a role in ovarian cancer adjuvant therapy
- (2011) Lei Tang et al. MEDICAL HYPOTHESES
- Osteopontin-c Splicing Isoform Contributes to Ovarian Cancer Progression
- (2011) T. M. Tilli et al. MOLECULAR CANCER RESEARCH
- Neutralizing Monoclonal Antibody to Periostin Inhibits Ovarian Tumor Growth and Metastasis
- (2011) M. Zhu et al. MOLECULAR CANCER THERAPEUTICS
- Emerging therapeutic targets in endometrial cancer
- (2011) Konstantin J. Dedes et al. Nature Reviews Clinical Oncology
- Harnessing synthetic lethal interactions in anticancer drug discovery
- (2011) Denise A. Chan et al. NATURE REVIEWS DRUG DISCOVERY
- The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
- (2011) X Zhang et al. ONCOGENE
- Estrogen Receptor Alpha Expression in Ovarian Cancer Predicts Longer Overall Survival
- (2011) Agnieszka Halon et al. PATHOLOGY & ONCOLOGY RESEARCH
- Changes in Gene Expression and Cellular Architecture in an Ovarian Cancer Progression Model
- (2011) Amy L. Creekmore et al. PLoS One
- Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity
- (2011) Robert Strauss et al. PLoS One
- BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability
- (2011) A. Aly et al. Journal of Molecular Cell Biology
- The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer
- (2011) Lucia M. A. Crane et al. CELLULAR ONCOLOGY
- Pre- and post-translational regulation of osteopontin in cancer
- (2011) Pieter H. Anborgh et al. Journal of Cell Communication and Signaling
- Potential Markers for Detection and Monitoring of Ovarian Cancer
- (2011) Brandon J. D. Rein et al. Journal of Oncology
- Multidrug Resistance Gene (MDR-1) and Risk of Brain Metastasis in Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
- (2010) Koji Matsuo et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Pericytes and vessel maturation during tumor angiogenesis and metastasis
- (2010) Ahmad Raza et al. AMERICAN JOURNAL OF HEMATOLOGY
- Regulation of Inflammation by the NF-κB Pathway in Ovarian Cancer Stem Cells
- (2010) Aliza L. Leizer et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Immunohistochemical expression of epidermal growth factor receptor, E-cadherin, and matrix metalloproteinase–9 in ovarian epithelial cancer and relation to patient deaths
- (2010) Hanan AlSaeid Alshenawy Annals of Diagnostic Pathology
- Identification of early predictive imaging biomarkers and their relationship to serological angiogenic markers in patients with ovarian cancer with residual disease following cytotoxic therapy
- (2010) C. L. Mitchell et al. ANNALS OF ONCOLOGY
- Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval
- (2010) S. B. Kaye et al. ANNALS OF ONCOLOGY
- A review of PARP inhibitors: from bench to bedside
- (2010) C. Underhill et al. ANNALS OF ONCOLOGY
- Clinical Outcome of Tertiary Surgical Cytoreduction in Patients with Recurrent Epithelial Ovarian Cancer
- (2010) Christina Fotopoulou et al. ANNALS OF SURGICAL ONCOLOGY
- The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer
- (2010) Stephen C. L. Koh et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: A possible target for combination therapy with anti-proliferative aminopeptidase inhibitors
- (2010) Xuetao Fan et al. BIOCHEMICAL PHARMACOLOGY
- Antiangiogenic agents and targets: A perspective
- (2010) Beverly A. Teicher BIOCHEMICAL PHARMACOLOGY
- Functional proteomics of kallikrein-related peptidases in ovarian cancer ascites fluid
- (2010) Katerina Oikonomopoulou et al. BIOLOGICAL CHEMISTRY
- Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer
- (2010) N M A White et al. BRITISH JOURNAL OF CANCER
- Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer
- (2010) Lisa M. Hess et al. CANCER
- The molecular pathogenesis of hereditary ovarian carcinoma
- (2010) Barbara M. Norquist et al. CANCER
- Reducing ovarian cancer death rates through screening
- (2010) Patricia Hartge CANCER
- Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer
- (2010) Gisele A. Sarosy et al. CANCER
- Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal
- (2010) Andrea Tinelli et al. CANCER AND METASTASIS REVIEWS
- PI3K: a rational target for ovarian cancer therapy?
- (2010) Paul Dent et al. CANCER BIOLOGY & THERAPY
- Possible angiogenic roles for claudin-4 in ovarian cancer
- (2010) Jianghong Li et al. CANCER BIOLOGY & THERAPY
- Blockade of FGF signaling: Therapeutic promise for ovarian cancer
- (2010) Mircea Ivan et al. CANCER BIOLOGY & THERAPY
- Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
- (2010) Yue Wang et al. CANCER LETTERS
- Inhibition of Histone Deacetylase in Cancer Cells Slows Down Replication Forks, Activates Dormant Origins, and Induces DNA Damage
- (2010) Chiara Conti et al. CANCER RESEARCH
- Identification of a Metalloprotease-Chemokine Signaling System in the Ovarian Cancer Microenvironment: Implications for Antiangiogenic Therapy
- (2010) A. Agarwal et al. CANCER RESEARCH
- Synergistic Enhancement of Carboplatin Efficacy with Photodynamic Therapy in a Three-Dimensional Model for Micrometastatic Ovarian Cancer
- (2010) I. Rizvi et al. CANCER RESEARCH
- IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer
- (2010) Chi-Wen Lo et al. CANCER RESEARCH
- Activation of NF- B Signaling by Inhibitor of NF- B Kinase Increases Aggressiveness of Ovarian Cancer
- (2010) L. Hernandez et al. CANCER RESEARCH
- Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment
- (2010) N. Chan et al. CANCER RESEARCH
- Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers
- (2010) C. J. Creighton et al. CANCER RESEARCH
- Rab5a overexpression promoting ovarian cancer cell proliferation may be associated with APPL1-related epidermal growth factor signaling pathway
- (2010) Zhen Zhao et al. CANCER SCIENCE
- Secondary mutations of BRCA1/2 and drug resistance
- (2010) Kiranjit K. Dhillon et al. CANCER SCIENCE
- Farletuzumab, a Humanized Monoclonal Antibody against Folate Receptor , in Epithelial Ovarian Cancer: a Phase I Study
- (2010) J. A. Konner et al. CLINICAL CANCER RESEARCH
- Successful Eradication of Established Peritoneal Ovarian Tumors in SCID-Beige Mice following Adoptive Transfer of T Cells Genetically Targeted to the MUC16 Antigen
- (2010) A. A. Chekmasova et al. CLINICAL CANCER RESEARCH
- Poly (ADP-Ribose) Polymerase as a Novel Therapeutic Target in Cancer
- (2010) C. M. Annunziata et al. CLINICAL CANCER RESEARCH
- Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer
- (2010) Y. Guo et al. CLINICAL CANCER RESEARCH
- Vandetanib, Designed to Inhibit VEGFR2 and EGFR Signaling, Had No Clinical Activity as Monotherapy for Recurrent Ovarian Cancer and No Detectable Modulation of VEGFR2
- (2010) C. M. Annunziata et al. CLINICAL CANCER RESEARCH
- CA125 Immune Complexes in Ovarian Cancer Patients with Low CA125 Concentrations
- (2010) D. W. Cramer et al. CLINICAL CHEMISTRY
- Increased plasma concentrations of anterior gradient 2 protein are positively associated with ovarian cancer
- (2010) Tracey A. Edgell et al. CLINICAL SCIENCE
- Epithelial ovarian cancer: Focus on targeted therapy
- (2010) Kyriaki Pliarchopoulou et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Biomolecular Pathogenesis of Borderline Ovarian Tumors: Focusing Target Discovery Through Proteogenomics
- (2010) D. Vergara et al. CURRENT CANCER DRUG TARGETS
- The Epithelial-Mesenchymal Transition and the Estrogen-Signaling in Ovarian Cancer
- (2010) D. Gallo et al. CURRENT DRUG TARGETS
- Targeting inhibitory pathways in cancer immunotherapy
- (2010) Marcio O Lasaro et al. CURRENT OPINION IN IMMUNOLOGY
- Stem cells and reproduction
- (2010) Hongling Du et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- ‘Triple negative’ epithelial ovarian cancer and pathologic markers for prognosis
- (2010) Naifu Liu et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Targeting the heparin-binding epidermal growth factor-like growth factor in ovarian cancer therapy
- (2010) Hiroshi Tsujioka et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- PARP inhibition: targeting the Achillesʼ heel of DNA repair to treat germline and sporadic ovarian cancers
- (2010) Craig P Carden et al. CURRENT OPINION IN ONCOLOGY
- The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma
- (2010) B. Davidson CYTOPATHOLOGY
- Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis
- (2010) Roel H Wilting et al. EMBO JOURNAL
- The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
- (2010) S. Leskela et al. ENDOCRINE-RELATED CANCER
- The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor
- (2010) Christine Bolitho et al. ENDOCRINE-RELATED CANCER
- First-line therapy for ovarian cancer with carboplatin followed by paclitaxel–gemcitabine (SCOTROC5): A feasibility study and comparative analysis of the SCOTROC series
- (2010) Roshan Agarwal et al. EUROPEAN JOURNAL OF CANCER
- Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1α from human mesenchymal stem cells
- (2010) Eun Su Jeon et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Tumor markers for early detection of ovarian cancer
- (2010) Juan Ren et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression
- (2010) T. Yamaguchi et al. GENES & DEVELOPMENT
- Germline copy number variations in BRCA1-associated ovarian cancer patients
- (2010) Kosuke Yoshihara et al. GENES CHROMOSOMES & CANCER
- Molecular characterization of ovarian cancer by gene-expression profiling
- (2010) C. Gómez-Raposo et al. GYNECOLOGIC ONCOLOGY
- Notch 1 signaling is active in ovarian cancer
- (2010) Stephen L. Rose et al. GYNECOLOGIC ONCOLOGY
- MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
- (2010) Zhimin Li et al. GYNECOLOGIC ONCOLOGY
- Achievements and unmet needs in the management of advanced ovarian cancer
- (2010) Valentina Guarneri et al. GYNECOLOGIC ONCOLOGY
- Periostin promotes ovarian cancer angiogenesis and metastasis
- (2010) Min Zhu et al. GYNECOLOGIC ONCOLOGY
- Surgical management of recurrent ovarian cancer: The advantage of collaborative surgical management and a multidisciplinary approach
- (2010) Elizabeth Burton et al. GYNECOLOGIC ONCOLOGY
- Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study of the Gynecologic Oncology Group
- (2010) Charles A. Kunos et al. GYNECOLOGIC ONCOLOGY
- Status of tumor markers in epithelial ovarian cancer has there been any progress? A review
- (2010) Nader Husseinzadeh GYNECOLOGIC ONCOLOGY
- Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment
- (2010) Giovanni D. Aletti et al. GYNECOLOGIC ONCOLOGY
- Immunoglobulin-like cell adhesion molecules: Novel signaling players in epithelial ovarian cancer
- (2010) Lorenzo Bombardelli et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Lysophosphatidic acid-induced expression of periostin in stromal cells: Prognoistic relevance of periostin expression in epithelial ovarian cancer
- (2010) Kyung Un Choi et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12
- (2010) Raphael Lis et al. INTERNATIONAL JOURNAL OF CANCER
- How to kill tumor cells with inhibitors of poly(ADP-ribosyl)ation
- (2010) Aswin Mangerich et al. INTERNATIONAL JOURNAL OF CANCER
- Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin
- (2010) Akiko Hayashi et al. INTERNATIONAL JOURNAL OF CANCER
- Human Kallikrein 5
- (2010) Elisabetta Bandiera et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Kallikrein-Related Peptidase 10 (KLK10) Expression and Single Nucleotide Polymorphisms in Ovarian Cancer Survival
- (2010) Jyotsna Batra et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Regulating the Regulators: The Post-Translational Code of Class I HDAC1 and HDAC2
- (2010) Chiara V. Segré et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Phase II biomarker trial of a multimarker diagnostic for ovarian cancer
- (2010) Tracey Edgell et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Role of the metastasis-promoting protein osteopontin in the tumour microenvironment
- (2010) Pieter H. Anborgh et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Gene Expression Profile ofBRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
- (2010) Panagiotis A. Konstantinopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Personalizing Therapy for Ovarian Cancer:BRCAness and Beyond
- (2010) Robert C. Bast et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial
- (2010) Daniela Matei et al. JOURNAL OF CLINICAL ONCOLOGY
- Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: A Randomized Multicenter Phase II Trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group
- (2010) Jalid Sehouli et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of midkine and anterior gradient 2 in a multimarker panel for the detection of ovarian cancer
- (2010) Gregory E Rice et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Expression pattern of the class I homeobox genes in ovarian carcinoma
- (2010) Jin Hwa Hong et al. Journal of Gynecologic Oncology
- Chitosan/pshRNA plasmid nanoparticles targeting MDR1 gene reverse paclitaxel resistance in ovarian cancer cells
- (2010) Yan Yang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Oxaliplatin-based hyperthermic intraperitoneal chemotherapy in primary or recurrent epithelial ovarian cancer: A pilot study of 31 patients
- (2010) Jean-Sebastien Frenel et al. JOURNAL OF SURGICAL ONCOLOGY
- PARP inhibition in BRCA-mutated breast and ovarian cancers
- (2010) Stephen L Chan et al. LANCET
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- Differential requirement of the epidermal growth factor receptor for G protein-mediated activation of transcription factors by lysophosphatidic acid
- (2010) Regina A Oyesanya et al. Molecular Cancer
- An essential role for Ran GTPase in epithelial ovarian cancer cell survival
- (2010) Véronique Barrès et al. Molecular Cancer
- Combination Drug Delivery Strategy for the Treatment of Multidrug Resistant Ovarian Cancer
- (2010) Payam Zahedi et al. MOLECULAR PHARMACEUTICS
- Enhancing the Therapeutic Effect Against Ovarian Cancer Through a Combination of Viral Oncolysis and Antigen-specific Immunotherapy
- (2010) Yu-Qian Zhang et al. MOLECULAR THERAPY
- NF-κB addiction and its role in cancer: ‘one size does not fit all’
- (2010) M M Chaturvedi et al. ONCOGENE
- Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes
- (2010) K Yamaguchi et al. ONCOGENE
- Expression of the Major Fas Family and Bcl-2 Family of Proteins in Epithelial Ovarian Cancer (EOC) and Their Correlation to Chemotherapeutic Response and Outcome
- (2010) Parvesh Chaudhry et al. ONCOLOGY RESEARCH
- Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin
- (2010) Siti S Abdullah-Soheimi et al. Proteome Science
- A cancer stem cell origin for human endometrial carcinoma?
- (2010) Sonya A Hubbard et al. REPRODUCTION
- Cancer stem cells in solid tumors
- (2010) Patrick C. Hermann et al. SEMINARS IN CANCER BIOLOGY
- Combined use of biomarkers for detection of ovarian cancer in high-risk women
- (2010) Martin Donach et al. TUMOR BIOLOGY
- Lysophosphatidic acid (LPA)—a perspective marker in ovarian cancer
- (2010) Iva Sedláková et al. TUMOR BIOLOGY
- Targeted Therapies in Epithelial Ovarian Cancer
- (2010) Emma Dean et al. Cancers
- Targeted Therapy in Ovarian Cancer
- (2010) Lyndsay J. Willmott et al. Journal of Oncology
- Validation of serum biomarkers for detection of early-stage ovarian cancer
- (2009) Vladimir Nosov et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Inhibition of P-glycoprotein-mediated docetaxel efflux sensitizes ovarian cancer cells to concomitant docetaxel and SN-38 exposure
- (2009) Susanna Miettinen et al. ANTI-CANCER DRUGS
- The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers
- (2009) Nicolas Jonckheere et al. BIOCHIMIE
- Current status of mucins in the diagnosis and therapy of cancer
- (2009) Satyanarayana Rachagani et al. BIOFACTORS
- Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer
- (2009) Jianghong Li et al. BMC CANCER
- The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer
- (2009) X B Trinh et al. BRITISH JOURNAL OF CANCER
- Influence of Ovarian Cancer Risk Status on the Diagnostic Performance of the Serum Biomarkers Mesothelin, HE4, and CA125
- (2009) C. A. Shah et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: Their inhibition by curcumin
- (2009) Ji Hye Seo et al. CANCER LETTERS
- Side population and cancer stem cells: Therapeutic implications
- (2009) Lidia Moserle et al. CANCER LETTERS
- Epithelial–mesenchymal transition in ovarian cancer
- (2009) Daniele Vergara et al. CANCER LETTERS
- Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapy
- (2009) Mrudula Mathew et al. CANCER SCIENCE
- The multifaceted role of periostin in tumorigenesis
- (2009) Kai Ruan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- MicroRNAs: Novel Biomarkers for Human Cancer
- (2009) C. L. Bartels et al. CLINICAL CHEMISTRY
- Prostasin, a potential tumor marker in ovarian cancer: a pilot study
- (2009) Fernanda Pires Costa et al. Clinics
- Addressing the Challenge: Current and Future Directions in Ovarian Cancer Therapy
- (2009) Tranum Kaur et al. CURRENT GENE THERAPY
- New therapeutic agents in ovarian cancer
- (2009) Fiona Collinson et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Current Status on Biologic Therapies in the Treatment of Epithelial Ovarian Cancer
- (2009) Ernest S. Han et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Reciprocal regulation of 17β-estradiol, interleukin-6 and interleukin-8 during growth and progression of epithelial ovarian cancer
- (2009) Jie Yang et al. CYTOKINE
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
- (2009) Sergei I. Grivennikov et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Pathways mediating VEGF-independent tumor angiogenesis
- (2009) Napoleone Ferrara CYTOKINE & GROWTH FACTOR REVIEWS
- Histone Deacetylase Inhibitors
- (2009) Xujun Ma et al. DRUGS
- IKK/NF-κB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis
- (2009) Julia Bollrath et al. EMBO REPORTS
- Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy
- (2009) Hai-Yan Zhang et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Role of HDAC1 in senescence, aging, and cancer
- (2009) Danielle Willis-Martinez et al. EXPERIMENTAL GERONTOLOGY
- The rationale for mTOR inhibition in epithelial ovarian cancer
- (2009) Xuan Bich Trinh et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- HE4 as a biomarker for ovarian and endometrial cancer management
- (2009) Jinping Li et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Pathogenesis of ovarian cancer: clues from selected overexpressed genes
- (2009) Ie-Ming Shih et al. Future Oncology
- A phase II study of GM-CSF and rIFN-γ1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer
- (2009) Kathleen M. Schmeler et al. GYNECOLOGIC ONCOLOGY
- A review of the current evidence for maintenance therapy in ovarian cancer
- (2009) Talia Foster et al. GYNECOLOGIC ONCOLOGY
- CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis
- (2009) Marianne Boivin et al. GYNECOLOGIC ONCOLOGY
- Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer
- (2009) M. Robyn Andersen et al. GYNECOLOGIC ONCOLOGY
- Cetuximab Retargeting of Adenovirus via the Epidermal Growth Factor Receptor for Treatment of Intraperitoneal Ovarian Cancer
- (2009) Joanne Morrison et al. HUMAN GENE THERAPY
- Cleaved caspase-3 and nuclear factor-κB p65 are prognostic factors in metastatic serous ovarian carcinoma
- (2009) Lilach Kleinberg et al. HUMAN PATHOLOGY
- Immuno-Modulatory Gene Polymorphisms and Outcome in Breast and Ovarian Cancer
- (2009) Sarah Kim et al. IMMUNOLOGICAL INVESTIGATIONS
- Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway
- (2009) Her-Young Su et al. INTERNATIONAL JOURNAL OF CANCER
- Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation
- (2009) Reinhard Brunmeir et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Trans-regulation of Histone Deacetylase Activities through Acetylation
- (2009) Yi Luo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
- (2009) R. Rattan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Histone deacetylase inhibitors: Potential in cancer therapy
- (2009) P.A. Marks et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies
- (2009) Brett G. Hollier et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Intraperitoneal Therapy for Ovarian Cancer: Why Has It Not Become Standard?
- (2009) Karen Rowan JNCI-Journal of the National Cancer Institute
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- Epidermal Growth Factor-Induced GnRH-II Synthesis Contributes to Ovarian Cancer Cell Invasion
- (2009) Song Ling Poon et al. MOLECULAR ENDOCRINOLOGY
- Treatment With Cyclooxygenase-2 Inhibitors Enables Repeated Administration of Vaccinia Virus for Control of Ovarian Cancer
- (2009) Chih-Long Chang et al. MOLECULAR THERAPY
- Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
- (2009) Bin-Bing S. Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Future of Targeted Therapies in Ovarian Cancer
- (2009) S. Banerjee et al. ONCOLOGIST
- Estrogen and progestin regulate HIF-1α expression in ovarian cancer cell lines via the activation of Akt signaling transduction pathway
- (2009) Feng ONCOLOGY REPORTS
- Functional Folate Receptor Alpha Is Elevated in the Blood of Ovarian Cancer Patients
- (2009) Eati Basal et al. PLoS One
- Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis
- (2009) Karen L. Abbott et al. PROTEOMICS
- The functional role of cell adhesion molecules in tumor angiogenesis
- (2009) Chiara Francavilla et al. SEMINARS IN CANCER BIOLOGY
- Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis
- (2009) Panteleimon Kountourakis et al. THROMBOSIS AND HAEMOSTASIS
- Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies
- (2009) Yongping Crawford et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Mucins in ovarian cancer diagnosis and therapy
- (2009) Subhash C Chauhan et al. Journal of Ovarian Research
- Targeting the EGF Receptor for Ovarian Cancer Therapy
- (2009) Reema Zeineldin et al. Journal of Oncology
- Antivascular Therapy for Epithelial Ovarian Cancer
- (2009) Francois P. Duhoux et al. Journal of Oncology
- Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges
- (2009) Doris R. Siwak et al. Journal of Oncology
- Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer
- (2008) Jacqueline M. Lafky et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
- (2008) Joshua Z Press et al. BMC CANCER
- The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
- (2008) P de Graeff et al. BRITISH JOURNAL OF CANCER
- Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs
- (2008) R Bianco et al. BRITISH JOURNAL OF CANCER
- Antiangiogenic drugs in ovarian cancer
- (2008) G C Kumaran et al. BRITISH JOURNAL OF CANCER
- Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas
- (2008) M Colomiere et al. BRITISH JOURNAL OF CANCER
- Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
- (2008) Sergei Grivennikov et al. CANCER CELL
- CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells
- (2008) Zhenfeng Duan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy
- (2008) Constantin N. Baxevanis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer
- (2008) Tianqian Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- Drug Resistance Caused by Reversion Mutation
- (2008) A. Ashworth CANCER RESEARCH
- MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
- (2008) N. Yang et al. CANCER RESEARCH
- The Adenocarcinoma-Associated Antigen, AGR2, Promotes Tumor Growth, Cell Migration, and Cellular Transformation
- (2008) Z. Wang et al. CANCER RESEARCH
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- Secondary BRCA1 Mutations in BRCA1-Mutated Ovarian Carcinomas with Platinum Resistance
- (2008) E. M. Swisher et al. CANCER RESEARCH
- Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA)
- (2008) Panteleimon Kountourakis et al. CANCER SCIENCE
- ABCB1 (MDR 1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy
- (2008) S. E. Johnatty et al. CLINICAL CANCER RESEARCH
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies
- (2008) Farbod Shojaei et al. DRUG RESISTANCE UPDATES
- Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
- (2008) J LOPICCOLO et al. DRUG RESISTANCE UPDATES
- Targeting signaling pathways in ovarian cancer
- (2008) J Reibenwein et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Osteopontin as a target for cancer therapy
- (2008) Nicholas IF Johnston Frontiers in Bioscience-Landmark
- Role of microRNAs in drug-resistant ovarian cancer cells
- (2008) Antonio Sorrentino et al. GYNECOLOGIC ONCOLOGY
- Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: A Gynecologic Oncology Group study
- (2008) Angeles Alvarez Secord et al. GYNECOLOGIC ONCOLOGY
- Folate receptor alpha as a tumor target in epithelial ovarian cancer
- (2008) Kimberly R. Kalli et al. GYNECOLOGIC ONCOLOGY
- Urinary levels of Bcl-2 are elevated in ovarian cancer patients
- (2008) Nicole S. Anderson et al. GYNECOLOGIC ONCOLOGY
- Claudin upregulation in ovarian carcinoma effusions is associated with poor survival
- (2008) Lilach Kleinberg et al. HUMAN PATHOLOGY
- Signaling defects in anti-tumor T cells
- (2008) Alan B. Frey et al. IMMUNOLOGICAL REVIEWS
- Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of α6β1 integrin
- (2008) Michelle Colomiere et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer
- (2008) Johanne Weberpals et al. INTERNATIONAL JOURNAL OF CANCER
- The emerging role of epidermal growth factor receptor inhibitors in ovarian cancer
- (2008) M.J. PALAYEKAR et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Alteration of cell-cycle regulation in epithelial ovarian cancer
- (2008) E.J. NAM et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Interleukin-6 and leptin as markers of energy metabolicchanges in advanced ovarian cancer patients
- (2008) Antonio Macciò et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cancer Stem Cells: A Step Toward the Cure
- (2008) Bruce M. Boman et al. JOURNAL OF CLINICAL ONCOLOGY
- Lysophosphatidic Acid Receptors Determine Tumorigenicity and Aggressiveness of Ovarian Cancer Cells
- (2008) Shuangxing Yu et al. JNCI-Journal of the National Cancer Institute
- Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth
- (2008) William M. Merritt et al. JNCI-Journal of the National Cancer Institute
- Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer
- (2008) Ajay P Singh et al. LANCET ONCOLOGY
- DifferentialN-glycosylation of Kallikrein 6 Derived from Ovarian Cancer Cells or the Central Nervous System
- (2008) Uros Kuzmanov et al. MOLECULAR & CELLULAR PROTEOMICS
- Heparin-binding epidermal growth factor–like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition
- (2008) Hiroshi Yagi et al. MOLECULAR CANCER THERAPEUTICS
- Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer
- (2008) Jane Bayani et al. Molecular Oncology
- Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
- (2008) Wataru Sakai et al. NATURE
- MicroRNAs accurately identify cancer tissue origin
- (2008) Nitzan Rosenfeld et al. NATURE BIOTECHNOLOGY
- Is NF-κB a good target for cancer therapy? Hopes and pitfalls
- (2008) Véronique Baud et al. NATURE REVIEWS DRUG DISCOVERY
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
- (2008) L. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
- (2008) S. Rottenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications
- (2008) Giampaolo Tortora et al. Nature clinical practice. Oncology
- Angiogenesis as a strategic target for ovarian cancer therapy
- (2008) Whitney A Spannuth et al. Nature clinical practice. Oncology
- The epidermal growth factor receptor (EGFR) is proteolytically modified by the Matriptase–Prostasin serine protease cascade in cultured epithelial cells
- (2007) Mengqian Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents
- (2007) Hilary P. Beck et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now